Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lin Tai-An | Chief Scientific Officer | 13 | $0 | $0 | 2025-07-01 |
| Cassidy James | Chief Medical Officer | 22 | $0 | $0 | 2025-07-01 |
| Ashar Bhavesh | Chief Commercial Officer | 32 | $0 | $443.6K | 2025-07-01 |
| Pichl Daniel | Chief People Officer | 46 | $0 | $3.56M | 2025-07-01 |
| Edris Badreddin | Chief Operating Officer | 45 | $0 | $10.55M | 2025-07-01 |
| Nofi Michael | Chief Accounting Officer | 26 | $0 | $0 | 2025-07-01 |
| Hambleton Julie | Director | 24 | $0 | $1.09M | 2025-07-01 |
| Islam Saqib | Chief Executive Officer | 60 | $0 | $31.21M | 2025-07-01 |
| ALBAN CARLOS | Director | 11 | $0 | $0 | 2025-07-01 |
| Lewis-Hall Freda C | Director, 10% Owner | 27 | $900.0K | $0 | 2025-07-01 |
| MACKAY MARTIN | Director | 5 | $0 | $0 | 2025-07-01 |
| Weinstein Herschel S | General Counsel and Secretary | 27 | $0 | $0 | 2025-07-01 |
| Perier Francis I Jr | Chief Financial Officer | 28 | $0 | $0 | 2025-07-01 |
| Fuhrman Alan | Director | 17 | $0 | $0 | 2025-07-01 |
| LYNCH DANIEL | Director, 10% Owner | 25 | $0 | $12.42M | 2025-07-01 |
| Smith L. Mary | See Remarks | 33 | $0 | $2.84M | 2024-01-08 |
| Schwartz Jeffrey Lawrence | Director, 10% Owner | 11 | $0 | $49.88M | 2023-05-24 |
| OrbiMed Capital GP VI LLC | 10% Owner | 4 | $0 | $106.96M | 2022-09-12 |
| ORBIMED ADVISORS LLC | 10% Owner | 15 | $4.95M | $23.37M | 2022-08-09 |
| Burgess Michael F. | Head of Research & Development | 7 | $0 | $0 | 2022-07-18 |
| SQUINTO STEPHEN P | Director, 10% Owner | 18 | $4.95M | $1.60M | 2022-05-19 |
| BC SW, LP | 10% Owner | 6 | $2.70M | $70.25M | 2021-08-10 |
| Koppel Adam | 10% Owner | 1 | $0 | $103.67M | 2021-03-09 |
| Renstrup Jens | Chief Medical Officer | 3 | $0 | $0 | 2021-01-07 |
| PFIZER INC | 10% Owner | 7 | $900.0K | $0 | 2019-09-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Weinstein Herschel S | General Counsel & Secretary | D To issuer deriv | 2025-07-01 | 2025-07-02 | 125,000 | — | $0 | 0 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | D To issuer deriv | 2025-07-01 | 2025-07-02 | 60,000 | — | $0 | 0 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | D To issuer deriv | 2025-07-01 | 2025-07-02 | 35,431 | — | $0 | 0 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | D To issuer deriv | 2025-07-01 | 2025-07-02 | 106,600 | — | $0 | 0 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,157 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 109,329 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 250,000 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 260,000 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 176,411 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 769,804 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 22,760 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 579,749 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 325,000 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 60,000 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 125,000 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 75,000 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 368,923 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 14,724 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 34,419 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 65,000 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 16,023 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 72,680 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 37,455 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 64,000 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 20,246 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 8,661 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 65,000 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 78,300 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 40,000 | — | $0 | 0 | SEC↗ |
| ALBAN CARLOS | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 30,160 | — | $0 | 0 | SEC↗ |
| ALBAN CARLOS | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| ALBAN CARLOS | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| MACKAY MARTIN | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,445 | — | $0 | 0 | SEC↗ |
| Cassidy James | Chief Medical Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 21,654 | — | $0 | 0 | SEC↗ |
| Cassidy James | Chief Medical Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 135,000 | — | $0 | 0 | SEC↗ |
| Cassidy James | Chief Medical Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 80,000 | — | $0 | 0 | SEC↗ |
| Cassidy James | Chief Medical Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 50,615 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 70,000 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 75,000 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 50,615 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 21,654 | — | $0 | 0 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 20,246 | — | $0 | 0 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,000 | — | $0 | 0 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 75,000 | — | $0 | 0 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 8,661 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,983 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 7,464 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| Hambleton Julie | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| Hambleton Julie | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| Hambleton Julie | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 14,668 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,983 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 7,464 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 232,376 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 6,447 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,983 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 7,464 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer deriv | 2025-07-01 | 2025-07-02 | 15,318 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 240,000 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 33,778 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 3,868 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 78,960 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 120,000 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer deriv | 2025-07-01 | 2025-07-02 | 149,470 | — | $0 | 0 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | D To issuer | 2025-07-01 | 2025-07-02 | 55,239 | — | $0 | 0 | SEC↗ |
| Islam Saqib | Chief Executive Officer | D To issuer | 2025-07-01 | 2025-07-02 | 954,869 | — | $0 | 0 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | D To issuer | 2025-07-01 | 2025-07-02 | 60,889 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | D To issuer | 2025-07-01 | 2025-07-02 | 50,762 | — | $0 | 0 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | D To issuer | 2025-07-01 | 2025-07-02 | 30,623 | — | $0 | 0 | SEC↗ |
| ALBAN CARLOS | Director | D To issuer | 2025-07-01 | 2025-07-02 | 28,861 | — | $0 | 0 | SEC↗ |
| MACKAY MARTIN | Director | D To issuer | 2025-07-01 | 2025-07-02 | 20,023 | — | $0 | 0 | SEC↗ |
| Cassidy James | Chief Medical Officer | D To issuer | 2025-07-01 | 2025-07-02 | 81,731 | — | $0 | 0 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | D To issuer | 2025-07-01 | 2025-07-02 | 62,053 | — | $0 | 0 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | D To issuer | 2025-07-01 | 2025-07-02 | 33,039 | — | $0 | 0 | SEC↗ |
| Fuhrman Alan | Director | D To issuer | 2025-07-01 | 2025-07-02 | 24,727 | — | $0 | 0 | SEC↗ |
| Hambleton Julie | Director | D To issuer | 2025-07-01 | 2025-07-02 | 14,155 | — | $0 | 0 | SEC↗ |
| Lewis-Hall Freda C | Director | D To issuer | 2025-07-01 | 2025-07-02 | 24,727 | — | $0 | 0 | SEC↗ |
| LYNCH DANIEL | Director | D To issuer | 2025-07-01 | 2025-07-02 | 93,004 | — | $0 | 0 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | D To issuer | 2025-07-01 | 2025-07-02 | 169,712 | — | $0 | 0 | SEC↗ |
| MACKAY MARTIN | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 20,023 | SEC↗ |
| ALBAN CARLOS | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 28,861 | SEC↗ |
| Fuhrman Alan | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 24,727 | SEC↗ |
| Hambleton Julie | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 14,155 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 24,727 | SEC↗ |
| LYNCH DANIEL | Director | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 93,004 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 23,600 | $54.24 | $1.28M | 968,469 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 11,600 | $55.15 | $639.7K | 956,869 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 1,400 | $56.13 | $78.6K | 955,469 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 600 | $56.89 | $34.1K | 954,869 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 11,800 | $52.97 | $625.0K | 992,069 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-05 | 400 | $56.20 | $22.5K | 169,712 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-05 | 3,924 | $53.12 | $208.4K | 185,788 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-05 | 12,078 | $54.26 | $655.4K | 173,710 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-05 | 3,598 | $55.12 | $198.3K | 170,112 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2025-02-27 | 2025-03-05 | 30,756 | $53.41 | $1.64M | 1,003,869 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-20 | 2025-02-24 | 44,018 | $60.14 | $2.65M | 86,526 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-20 | 2025-02-24 | 3,582 | $61.24 | $219.4K | 82,944 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2025-02-20 | 2025-02-24 | 1,016 | $61.19 | $62.2K | 62,053 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-02-20 | 2025-02-24 | 24,260 | $60.10 | $1.46M | 1,039,693 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-02-20 | 2025-02-24 | 5,068 | $61.24 | $310.4K | 1,034,625 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-14 | 2025-02-19 | 400 | $60.00 | $24.0K | 130,544 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-02-14 | 2025-02-19 | 10,672 | $59.92 | $639.5K | 1,063,953 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2025-02-12 | 2025-02-14 | 13,186 | $59.28 | $781.7K | 1,074,625 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award | 2025-02-12 | 2025-02-14 | 85,309 | — | $0 | 1,087,811 | SEC↗ |
| Hambleton Julie | Director | M Exercise deriv | 2025-02-10 | 2025-02-12 | 13,774 | — | $0 | 0 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise deriv | 2025-02-10 | 2025-02-12 | 13,750 | — | $0 | 31,250 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise deriv | 2025-02-10 | 2025-02-12 | 16,000 | — | $0 | 32,750 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2025-02-10 | 2025-02-12 | 30,000 | $53.13 | $1.59M | 189,712 | SEC↗ |
| Hambleton Julie | Director | M Exercise | 2025-02-10 | 2025-02-12 | 13,774 | $32.27 | $444.5K | 17,869 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2025-02-10 | 2025-02-12 | 13,774 | $53.01 | $730.2K | 4,095 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2025-02-10 | 2025-02-12 | 48,000 | $53.30 | $2.56M | 1,002,502 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-10 | 2025-02-12 | 65,600 | $55.51 | $3.64M | 130,944 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-10 | 2025-02-12 | 39,634 | $54.88 | $2.18M | 196,544 | SEC↗ |
| LYNCH DANIEL | Director | S Sale | 2025-02-10 | 2025-02-12 | 69,766 | $53.23 | $3.71M | 236,178 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2025-02-10 | 2025-02-12 | 13,750 | $53.02 | $729.0K | 66,762 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2025-02-10 | 2025-02-12 | 7,000 | $57.15 | $400.1K | 50,762 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise | 2025-02-10 | 2025-02-12 | 13,750 | $27.64 | $380.1K | 64,512 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2025-02-10 | 2025-02-12 | 9,000 | $54.25 | $488.3K | 57,762 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise | 2025-02-10 | 2025-02-12 | 16,000 | $27.64 | $442.2K | 80,512 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 50,615 | — | $0 | 50,615 | SEC↗ |
| Cassidy James | Chief Medical Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 50,615 | — | $0 | 50,615 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 78,960 | — | $0 | 78,960 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 109,329 | — | $0 | 109,329 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 20,246 | — | $0 | 20,246 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 20,246 | — | $0 | 20,246 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 34,419 | — | $0 | 34,419 | SEC↗ |
| Pichl Daniel | Chief People Officer | A Award deriv | 2025-01-10 | 2025-01-14 | 37,455 | — | $0 | 37,455 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | A Award deriv | 2025-01-10 | 2025-01-14 | 35,431 | — | $0 | 35,431 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | A Award | 2025-01-10 | 2025-01-14 | 17,323 | — | $0 | 63,069 | SEC↗ |
| Cassidy James | Chief Medical Officer | A Award | 2025-01-10 | 2025-01-14 | 17,323 | — | $0 | 81,731 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | A Award | 2025-01-10 | 2025-01-14 | 27,023 | — | $0 | 219,712 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award | 2025-01-10 | 2025-01-14 | 74,834 | — | $0 | 1,050,502 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award | 2025-01-10 | 2025-01-14 | 6,929 | — | $0 | 33,039 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | A Award | 2025-01-10 | 2025-01-14 | 6,929 | — | $0 | 30,623 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | A Award | 2025-01-10 | 2025-01-14 | 11,779 | — | $0 | 60,889 | SEC↗ |
| Pichl Daniel | Chief People Officer | A Award | 2025-01-10 | 2025-01-14 | 12,819 | — | $0 | 50,762 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | A Award | 2025-01-10 | 2025-01-14 | 12,126 | — | $0 | 55,239 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 1,658 | $38.86 | $64.4K | 64,408 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 4,416 | $38.86 | $171.6K | 192,689 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 12,359 | $38.86 | $480.3K | 975,668 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 1,009 | $38.86 | $39.2K | 23,694 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 3,283 | $38.86 | $127.6K | 49,110 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 1,759 | $38.86 | $68.4K | 37,943 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2025-01-06 | 2025-01-07 | 2,279 | $38.86 | $88.6K | 43,113 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2025-01-06 | 2025-01-07 | 2,284 | $38.86 | $88.8K | 45,746 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 3,465 | $38.19 | $132.3K | 66,066 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 5,561 | $38.19 | $212.4K | 197,105 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 12,872 | $38.19 | $491.6K | 988,027 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 1,636 | $38.19 | $62.5K | 24,703 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 3,278 | $38.19 | $125.2K | 52,393 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 2,522 | $38.19 | $96.3K | 39,702 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2025-01-05 | 2025-01-07 | 3,272 | $38.19 | $125.0K | 45,392 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2025-01-05 | 2025-01-07 | 3,825 | $38.19 | $146.1K | 48,030 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 4,325 | $38.19 | $165.2K | 69,531 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 6,934 | $38.19 | $264.8K | 202,666 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 13,469 | $38.19 | $514.4K | 1,000,899 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 855 | $38.19 | $32.7K | 26,110 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 2,388 | $38.19 | $91.2K | 26,339 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 3,582 | $38.19 | $136.8K | 55,671 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 2,988 | $38.19 | $114.1K | 42,224 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2025-01-04 | 2025-01-07 | 3,575 | $38.19 | $136.5K | 48,664 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2025-01-04 | 2025-01-07 | 4,475 | $38.19 | $170.9K | 51,855 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-12-03 | 2024-12-05 | 11,966 | $41.78 | $499.9K | 217,634 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-12-03 | 2024-12-05 | 8,034 | $42.24 | $339.4K | 209,600 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-12-02 | 2024-12-04 | 3,989 | $41.85 | $166.9K | 1,014,368 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-12-02 | 2024-12-04 | 45,011 | $41.33 | $1.86M | 1,018,357 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | F Tax w/h | 2024-10-02 | 2024-10-03 | 2,324 | $32.83 | $76.3K | 26,965 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-09-03 | 2024-09-04 | 4,620 | $41.12 | $190.0K | 232,680 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-09-03 | 2024-09-04 | 12,300 | $40.11 | $493.4K | 237,300 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-09-03 | 2024-09-04 | 3,080 | $42.08 | $129.6K | 229,600 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-09-03 | 2024-09-04 | 6,692 | $42.07 | $281.5K | 1,063,368 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-09-03 | 2024-09-04 | 9,908 | $41.10 | $407.2K | 1,070,060 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-09-03 | 2024-09-04 | 32,400 | $40.10 | $1.30M | 1,079,968 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2024-08-30 | 2024-09-03 | 1,969 | $41.71 | $82.1K | 73,856 | SEC↗ |
| MACKAY MARTIN | Director | A Award deriv | 2024-07-29 | 2024-07-30 | 29,445 | — | $0 | 29,445 | SEC↗ |
| MACKAY MARTIN | Director | A Award | 2024-07-29 | 2024-07-30 | 9,963 | — | $0 | 9,963 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2024-07-01 | 2024-07-02 | 591 | $38.53 | $22.8K | 75,825 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-06-03 | 2024-06-05 | 11,772 | $39.40 | $463.8K | 257,828 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-06-03 | 2024-06-05 | 4,192 | $40.62 | $170.3K | 253,636 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-06-03 | 2024-06-05 | 3,651 | $41.38 | $151.1K | 249,985 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | S Sale | 2024-06-03 | 2024-06-05 | 385 | $42.04 | $16.2K | 249,600 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2024-06-03 | 2024-06-05 | 2,946 | $39.41 | $116.1K | 5,797 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2024-06-03 | 2024-06-05 | 751 | $40.57 | $30.5K | 5,046 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2024-06-03 | 2024-06-05 | 20 | $42.09 | $842 | 4,095 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2024-06-03 | 2024-06-05 | 931 | $41.49 | $38.6K | 4,115 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-06-03 | 2024-06-05 | 33,240 | $39.40 | $1.31M | 1,128,128 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-06-03 | 2024-06-05 | 8,760 | $40.57 | $355.4K | 1,119,368 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-06-03 | 2024-06-05 | 400 | $42.09 | $16.8K | 1,112,368 | SEC↗ |
| Islam Saqib | Chief Executive Officer | S Sale | 2024-06-03 | 2024-06-05 | 6,600 | $41.40 | $273.2K | 1,112,768 | SEC↗ |
| ALBAN CARLOS | Director | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| Fuhrman Alan | Director | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| Hambleton Julie | Director | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| LYNCH DANIEL | Director | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| ALBAN CARLOS | Director | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 18,801 | SEC↗ |
| Fuhrman Alan | Director | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 14,667 | SEC↗ |
| Hambleton Julie | Director | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 8,743 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 14,667 | SEC↗ |
| LYNCH DANIEL | Director | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 305,944 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,824 | $47.62 | $86.9K | 56,330 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise deriv | 2024-02-16 | 2024-02-20 | 15,000 | — | $0 | 45,000 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2024-02-16 | 2024-02-20 | 15,000 | $50.10 | $751.5K | 45,212 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise | 2024-02-16 | 2024-02-20 | 15,000 | $27.64 | $414.6K | 60,212 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2024-02-05 | 2024-02-05 | 4,834 | $49.32 | $238.4K | 58,154 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise deriv | 2024-02-02 | 2024-02-05 | 16,250 | — | $0 | 48,750 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2024-02-02 | 2024-02-05 | 14,175 | $44.31 | $628.1K | 47,952 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2024-02-02 | 2024-02-05 | 743 | $46.44 | $34.5K | 45,212 | SEC↗ |
| Pichl Daniel | Chief People Officer | M Exercise | 2024-02-02 | 2024-02-05 | 16,250 | $27.64 | $449.1K | 71,393 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2024-02-02 | 2024-02-05 | 1,997 | $45.95 | $91.8K | 45,955 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2024-02-02 | 2024-02-05 | 9,266 | $43.81 | $405.9K | 62,127 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2024-02-02 | 2024-02-05 | 378 | $46.00 | $17.4K | 63,076 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2024-02-02 | 2024-02-05 | 1,089 | $43.75 | $47.6K | 65,121 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2024-02-02 | 2024-02-05 | 1,667 | $44.31 | $73.9K | 63,454 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | S Sale | 2024-02-02 | 2024-02-05 | 88 | $46.37 | $4.1K | 62,988 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 1,449 | $41.53 | $60.2K | 66,210 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 1,093 | $41.53 | $45.4K | 76,416 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 5,466 | $41.53 | $227.0K | 269,600 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 1,063 | $41.53 | $44.1K | 28,727 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 3,215 | $41.53 | $133.5K | 59,253 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 1,405 | $41.53 | $58.3K | 55,143 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 17,904 | $41.53 | $743.6K | 256,264 | SEC↗ |
| Smith L. Mary | Chief Development Officer | F Tax w/h | 2024-01-08 | 2024-01-08 | 3,535 | $41.53 | $146.8K | 233,363 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2024-01-08 | 2024-01-08 | 2,423 | $41.53 | $100.6K | 52,239 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,507 | $37.96 | $95.2K | 67,659 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,357 | $37.96 | $89.5K | 77,509 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 4,469 | $37.96 | $169.6K | 275,066 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 1,169 | $37.96 | $44.4K | 29,790 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,151 | $37.96 | $81.7K | 62,468 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 1,574 | $37.96 | $59.7K | 56,548 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 12,885 | $37.96 | $489.1K | 274,168 | SEC↗ |
| Smith L. Mary | Chief Development Officer | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,197 | $37.96 | $83.4K | 236,898 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,324 | $37.96 | $88.2K | 54,662 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Cassidy James | Chief Medical Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Pichl Daniel | Chief People Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Smith L. Mary | Chief Development Officer | A Award deriv | 2024-01-04 | 2024-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | A Award deriv | 2024-01-04 | 2024-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | A Award | 2024-01-04 | 2024-01-08 | 26,445 | — | $0 | 70,166 | SEC↗ |
| Cassidy James | Chief Medical Officer | A Award | 2024-01-04 | 2024-01-08 | 28,208 | — | $0 | 79,866 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | A Award | 2024-01-04 | 2024-01-08 | 42,312 | — | $0 | 279,535 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award | 2024-01-04 | 2024-01-08 | 5,289 | — | $0 | 29,289 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | A Award | 2024-01-04 | 2024-01-08 | 14,104 | — | $0 | 30,959 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | A Award | 2024-01-04 | 2024-01-08 | 21,156 | — | $0 | 64,619 | SEC↗ |
| Pichl Daniel | Chief People Officer | A Award | 2024-01-04 | 2024-01-08 | 22,919 | — | $0 | 58,122 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award | 2024-01-04 | 2024-01-08 | 88,000 | — | $0 | 287,053 | SEC↗ |
| Smith L. Mary | Chief Development Officer | A Award | 2024-01-04 | 2024-01-08 | 21,156 | — | $0 | 239,095 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | A Award | 2024-01-04 | 2024-01-08 | 21,156 | — | $0 | 56,986 | SEC↗ |
| Islam Saqib | Chief Executive Officer | A Award | 2023-11-30 | 2023-12-01 | 199,053 | — | $0 | 199,053 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award deriv | 2023-10-02 | 2023-10-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Lin Tai-An | Chief Scientific Officer | A Award | 2023-10-02 | 2023-10-04 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2023-09-01 | 2023-09-08 | 1,292 | $30.33 | $39.2K | 51,658 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2023-07-19 | 2023-07-21 | 2,418 | $29.31 | $70.9K | 4,648 | SEC↗ |
| Smith L. Mary | Chief Development Officer | A Award | 2023-06-30 | 2023-07-05 | 5,720 | — | $0 | 217,939 | SEC↗ |
| Cassidy James | Chief Medical Officer | A Award | 2023-06-30 | 2023-07-05 | 5,720 | — | $0 | 52,950 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2023-06-20 | 2023-06-22 | 2,400 | $26.92 | $64.6K | 7,066 | SEC↗ |
| ALBAN CARLOS | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| Fuhrman Alan | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| Hambleton Julie | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| LYNCH DANIEL | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| Schwartz Jeffrey Lawrence | Director | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| ALBAN CARLOS | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 14,706 | SEC↗ |
| Fuhrman Alan | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 10,572 | SEC↗ |
| Hambleton Julie | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 9,466 | SEC↗ |
| Lewis-Hall Freda C | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 10,572 | SEC↗ |
| LYNCH DANIEL | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 301,849 | SEC↗ |
| Schwartz Jeffrey Lawrence | Director | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 10,572 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2023-04-03 | 2023-04-05 | 1,375 | $25.25 | $34.7K | 43,721 | SEC↗ |
| Schwartz Jeffrey Lawrence | Director | S Sale | 2023-03-16 | 2023-03-20 | 1,750,000 | $28.50 | $49.88M | 3,081,307 | SEC↗ |
| Hambleton Julie | Director | S Sale | 2023-03-15 | 2023-03-16 | 1,106 | $31.50 | $34.8K | 4,818 | SEC↗ |
| Pichl Daniel | Chief People Officer | S Sale | 2023-01-26 | 2023-01-27 | 858 | $31.00 | $26.6K | 35,203 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2023-01-07 | 2023-01-10 | 909 | $26.41 | $24.0K | 35,830 | SEC↗ |
| Smith L. Mary | Chief Development Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 1,068 | $26.41 | $28.2K | 212,219 | SEC↗ |
| Perier Francis I Jr | Chief Financial Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 1,090 | $26.41 | $28.8K | 43,463 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 546 | $26.41 | $14.4K | 36,061 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 1,483 | $26.41 | $39.2K | 237,223 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 4,097 | $26.41 | $108.2K | 905,104 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2023-01-07 | 2023-01-10 | 409 | $26.41 | $10.8K | 16,855 | SEC↗ |
| Pichl Daniel | Chief People Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 1,719 | $27.52 | $47.3K | 36,607 | SEC↗ |
| Weinstein Herschel S | General Counsel & Secretary | F Tax w/h | 2023-01-06 | 2023-01-09 | 1,782 | $27.52 | $49.0K | 36,739 | SEC↗ |
| Ashar Bhavesh | Chief Commercial Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 1,665 | $27.52 | $45.8K | 45,096 | SEC↗ |
| Nofi Michael | Chief Accounting Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 783 | $27.52 | $21.5K | 17,264 | SEC↗ |
| Smith L. Mary | Chief Development Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 2,452 | $27.52 | $67.5K | 213,287 | SEC↗ |
| Cassidy James | Chief Medical Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 1,263 | $27.52 | $34.8K | 47,230 | SEC↗ |
| Edris Badreddin | Chief Operating Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 3,326 | $27.52 | $91.5K | 238,706 | SEC↗ |
| Islam Saqib | Chief Executive Officer | F Tax w/h | 2023-01-06 | 2023-01-09 | 8,400 | $27.52 | $231.2K | 909,201 | SEC↗ |